Dr. Arumugam “Ram” Manthiram on a Pandemic Wake-up Call

Ram Manthiram urges the science community to step up
The Electrochemical Society
26-Aug-2020 1:10 PM EDT, by The Electrochemical Society

Ram Manthiram urges the science community to step up

Newswise — In our series, The ECS Community Adapts and AdvancesArumugam “Ram” Manthiram urges the science community to be proactive in confronting the pandemic and climate change challenges threatening the global community. Ram is Director of the Texas Materials Institute and the Materials Science and Engineering Program at the University of Texas Austin (UTAUS). He holds a co-appointment as the Joe C. Walter Chair in Engineering and Jack S. Josey Professor in Energy Studies. Ram’s research group focuses on the design and development of affordable, efficient, durable materials for electrochemical energy conversion and storagespecifically, batteries and fuel cellsto address global energy and environmental challenges.

The future imperative

“I’m very optimistic. I see the ability to act in a unified way in our collective global response to the pandemic. If they had told me in January, “We’re going to shut the country down for seven weeks,” I would have said that’s impossible; it could never happen. But somehow, we rolled with it amazingly well. People supported each other. My main takeaways from the current situation are that we’re capable of collective action, and science and scientists are absolutely vital to solving these problems.

Health and climate change are the grand challenges now confronting society—and they are interconnected. That’s why all the sciences—electrochemistry, materials chemistry, biology—come into the picture, along with collective action.

The Society has a great role to play in solving these problems. The people who work with ECS—scientists and engineers, students and postdocs, young and old minds—have to be proactive, think positively, and do whatever we can to be prepared. Bringing people working in materials and electrochemistry together resulted in Lithium ion batteries which revolutionized the portable electronics industry and are on the verge of transforming the transportation sector. They will play a big role in the utility industry, too. Lithium ion batteries resulted from the beneficial marriage of electrochemistry and materials chemistry. The advances of the ’70s through today will continue into the future. We cannot be reactive and wait for the next train wreck.

I hope this is a wake-up call for policy makers across the world to heed the scientific community’s warnings, guidance, and insight. The global community must care about the situation and come together collectively to work the solutions.

My focus is experimental. If the shutdown is prolonged, it will be problematic. At some point, we have to get back in the lab. Research will start slowing down. And that is tragic, because we need research to continue on so many fronts.”

Maintaining productivity

“When I am in a leadership position, I don’t email and wait for the response. I accomplish more in a five-minute in-person meeting than is possible meeting remotely. With the pandemic, everything I did in the past still has to be done, but now that communication is by phone or Zoom, it’s added 20 to 30 percent to my workload. I guess people think that since I’m home, I’m not busy! However, we must make the most of this difficult situation. 

I’m blessed with a highly motivated, self-driven group. Knowing that the shut-down was imminent, I held a Zoom meeting with about 30 of my students, PhD candidates, and postdocs. We brainstormed and decided on the best uses of shutdown time.  Analyzing and organizing existing data and drafting manuscripts for submission is important. People with incomplete experiments process the data in hand, write introductions and discussions, and mark missing information with place holders so that when labs re-open, data is collected quickly, holes filled in, and articles submitted. Those whose work is completely experimental are learning modeling—something new, which they never imagined would happen during their PhDs. Others write or review articles and peruse the literature. This broadens views and helps future research by defining problems more clearly.”

Moving science forward

“If you look at the papers which really accomplished something from a practical or technology point of view, they were published in the Journal of the Electrochemical Society. There is no substitute for listening to and meeting these authors at ECS meetings—especially now, with the challenges we face. I am eager to exchange information with colleagues and longtime friends at the next live ECS meeting. ECS is not too big or out of control. If I want to see somebody, I can count on seeing them; not like other societies’ meetings that are spread across too many locations.

I was scheduled to present award talks at ECS, the International Battery Association, and World Academy of Ceramics; they were all postponed. I missed these opportunities to meet with my colleagues. While digital is not the same as presenting face-to-face, I successfully delivered my Henry B. Linford for Distinguished Teaching Award Address in an ECS webinar.”

Engage to meet the challenges of the future

“At meetings, I get great pleasure in meeting young people, the postdocs who want advice about their careers. I learned the importance of supporting young scientists from John Goodenough. He was the examiner on my PhD defense at the Indian Institute of Technology in Madras, India, and his support impacted everything in my life. John is a unique person, gentle, kind, supportive of the people who work with him, and an encyclopedia of knowledge. We have worked together for 40 years, from India, to Oxford University, UT Austin, and my presenting his Nobel Prize acceptance speech in Stockholm.

Young people are the future of science. Moving forward, ECS must continue encouraging students to join and become active in the Society’s operations. The size of our meetings is optimal for them to present their research and benefit from proximity to leaders in the field.

While I’m a member of other societies, I attend their meetings, present papers, listen to talks…that’s easy. But I feel that ECS, with which I have a long association, is mine. I’m part of the Society itself, making decisions, belonging to a community. My group research focuses largely on batteries and spans both battery division and the energy technology division. The ECS meetings are the best for us to attend to meet people, listen, learn, and understand, and also present. I’m happy to participate and donate more.” 




Filters close

Showing results

1120 of 4578
Released: 15-Jan-2021 1:30 PM EST
New England Journal of Medicine publishes COVID-19 treatment trial results
University of Texas at San Antonio

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.

Released: 15-Jan-2021 12:40 PM EST
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
University of Cambridge

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

Released: 15-Jan-2021 12:30 PM EST
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer

Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic

Released: 15-Jan-2021 12:25 PM EST
Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
American Technion Society

Israel's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.

Released: 15-Jan-2021 11:30 AM EST
UW researchers develop tool to equitably distribute limited vaccines
University of Wisconsin-Madison

Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.

Released: 15-Jan-2021 11:20 AM EST
Will Covid-19 kill the high street once and for all?
University of Sheffield

The shift to home working during Covid-19, or ‘Zoomshock’, threatens the survival of local goods and services provided in city centres and business parks

14-Jan-2021 5:00 PM EST
AACI Partners With Federal Vaccine Panel to Promote Cancer Patient Health
Association of American Cancer Institutes (AACI)

AACI was invited last summer to join the Vaccine Consultation Panel (VCP) alongside other leading health and science organizations in the U.S. Through the VCP, AACI has received periodic updates on the development and distribution of COVID-19 vaccines and participated in efforts to educate the cancer center community and the general public on the importance of widespread vaccine uptake.

Released: 15-Jan-2021 8:55 AM EST
The First Dose of the Pfizer Vaccine Gives About 50% COVID Protection, Not 91% Claimed by Those Who Want to Speed Up Immunization
Newswise

The NEJM paper actually states that the efficacy between the first and second doses was found to be 52 percent when given 21 days apart. After the second dose, the efficacy raises to 95 percent.

Released: 15-Jan-2021 8:20 AM EST
Houston Methodist study finds males of all ages more affected by COVID-19 than females
Houston Methodist

A new Houston Methodist study found males are more likely to test positive for COVID-19, have complications and die from the virus than females, independent of age. The peer-reviewed observational study appears in PLOS ONE, a multidisciplinary journal published by the Public Library of Science.

Released: 15-Jan-2021 8:20 AM EST
NIH Revises Treatment Guidelines for Ivermectin for the Treatment of COVID-19
Front Line COVID-19 Critical Care Alliance (FLCCC Alliance)

NIH Revises Treatment Guidelines for Ivermectin for the Treatment of COVID-19 Ivermectin is Now a Therapeutic Option for Doctors & Prescribers


Showing results

1120 of 4578

close
2.0365